SCHEMBL29519643

SCHEMBL29519643

C[C@H](NC(=O)[C@@H](N)CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 7/20 0.49
▸ NPY4R P50391 6/20 0.47
▸ NPY5R Q15761 5/20 0.47
▸ NPY1R P25929 5/20 0.47
▸ NPY2R P49146 2/20 0.47
▸ CTSD P07339 1/20 0.46
▸ GLP1R P43220 3/20 0.46
▸ SCTR P47872 1/20 0.46
▸ CTSL P07711 2/20 0.46
▸ CTSS P25774 2/20 0.46
▸ CTSK P43235 2/20 0.46
▸ CTSH P09668 1/20 0.46
▸ TUBB4A P04350 1/20 0.45
▸ TUBB P07437 1/20 0.45
▸ TUBA3C P0DPH7 1/20 0.45
▸ TUBA1B P68363 1/20 0.45
▸ TUBA4A P68366 1/20 0.45
▸ TUBB4B P68371 1/20 0.45
▸ TUBB3 Q13509 1/20 0.45
▸ TUBB2A Q13885 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29387939 0.94 PTPN1 (0.48) BACE1NPY4RNPY5RNPY1RGLP1R
SCHEMBL29519546 0.94 NPY4R (0.45) BACE1NPY4RNPY5RNPY1RNPY2R
SCHEMBL30252503 0.93 NPY4R (0.54) BACE1NPY4RNPY5RNPY1RNPY2R
SCHEMBL29840375 0.93 GLP1R (0.47) BACE1NPY4RNPY5RNPY1RGLP1R
SCHEMBL29476637 0.92 NPY4R (0.45) BACE1NPY4RNPY5RNPY1RNPY2R
SCHEMBL29476479 0.91 FNTA (0.49) NPY4RNPY5RNPY1RNPY2RTUBB4A
SCHEMBL29511116 0.91 FNTA (0.47) NPY4RNPY5RNPY1RNPY2RGLP1R
SCHEMBL29684563 0.91 NPY4R (0.51) NPY4RNPY5RNPY1RNPY2RGLP1R
SCHEMBL30845345 0.90 NPY4R (0.47) BACE1NPY4RNPY5RNPY1RNPY2R
SCHEMBL30956347 0.90 GLP1R (0.51) BACE1GLP1RSCTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124612-A1 MOLECULES WITH ALTERED NEONATE FC RECEPTOR BINDING HAVING ENHANCED THERAPEUTIC AND DIAGNOSTIC PROPERTIES MEDIMMUNE LLC 2024-04-18 — — US disclosed
US-11767369-B2 Molecules with altered neonate Fc receptor binding having enhanced therapeutic and diagnostic properties MEDIMMUNE, LLC (US) 2023-09-26 — — US disclosed
CN-106413750-B Molecules with altered neonatal Fc receptor binding with enhanced therapeutic and diagnostic properties 免疫医疗有限责任公司 2022-04-29 — — CN disclosed
Send feedback